Skip to main content
Premium Trial:

Request an Annual Quote

Selah Genomics' mySUDDinCode

Selah Genomics has launched a new assay, mySUDDinCode, as part of its partnership with South Carolina's Greenville Health System. The test involves comprehensive analysis of 55 genes related to arrhythmias and other abnormalities that can lead to sudden cardiac death. Results of the test are reviewed and interpreted by cardiologist Ramon Brugada as part of a collaboration between Selah and the Brugada Institute.